PUMA BIOTECHNOLOGY, INC.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2026 | $0 | $128.4M | $36.2M |
| Jun 2026 | $0 | $138.5M | $36.5M |
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2026 | $0 | $128.4M | $36.2M |
| Jun 2026 | $0 | $138.5M | $36.5M |